As we head into January 2026, investors and analysts are closely scrutinizing UnitedHealth Group (UNH) to determine whether ...
UnitedHealth Group has had a tumultuous year, marred by poor performance and controversy. Eli Lilly has thrived as it's taken control of the obesity drug market. Adding context to stock valuations can ...